Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
RegeneRx Biopharmaceuticals
AddedFeb 20, 2024
UpdatedJun 18, 2026
RegeneRx Biopharmaceuticals

RegeneRx Biopharmaceuticals

Public

US-based RegeneRx Biopharmaceuticals specializes in commercializing Thymosin beta 4 for rapid tissue repair and regeneration.

HQ
Rockville, MD, US
Founded
1982
Overview
Compare
Fundraising
Employees

RegeneRx Biopharmaceuticals, based in Rockville, United States, focuses on commercializing Thymosin beta 4, a 43 amino acid peptide. The company aims to enhance the treatment of injured tissue and non-healing wounds, promoting faster repair and tissue regeneration.

RegeneRx has made significant strides in the biopharmaceutical industry by advancing the therapeutic applications of Thymosin beta 4. Their innovative approach has the potential to revolutionize wound care and tissue repair, positioning them as a key player in regenerative medicine.

RegeneRx Biopharmaceuticals - Similar Companies

RegenX logo

RegenX

Regenxbio logo

Regenxbio

regenxbio.com

SironRX Therapeutics logo

SironRX Therapeutics

sironrx.com

BioRegenx logo

BioRegenx

bioregenx.com

Endogena Therapeutics logo

Endogena Therapeutics

AgeX Therapeutics logo

AgeX Therapeutics

Regen BioPharma logo

Regen BioPharma

RegenX Science logo

RegenX Science

regenxscience.com

Histogen logo

Histogen

histogen.com

Regenemed logo

Regenemed

regenemed.com

BioTissue logo

BioTissue

biotissue.com

Tissue Regeneration logo

Tissue Regeneration

Regenacy Pharmaceuticals logo

Regenacy Pharmaceuticals

InGeneron logo

InGeneron

ingeneron.com

Caeregen Therapeutics logo

Caeregen Therapeutics

caeregen.com

RegeneRx Biopharmaceuticals - Quick Facts

Who are RegeneRx Biopharmaceuticals' competitors?

Companies similar to RegeneRx Biopharmaceuticals include RegenX, Regenxbio, SironRX Therapeutics and BioRegenx.

When was RegeneRx Biopharmaceuticals founded?

RegeneRx Biopharmaceuticals was founded in 1982.

Where is RegeneRx Biopharmaceuticals' headquarters located?

RegeneRx Biopharmaceuticals' headquarters is located in Rockville, MD, US.

When was RegeneRx Biopharmaceuticals' last funding round?

RegeneRx Biopharmaceuticals' most recent funding round was for $2M (USD) in June 2021.

How much has RegeneRx Biopharmaceuticals raised to-date?

As of Jun 28, 2021, RegeneRx Biopharmaceuticals has raised a total of $11.7M (USD).

How many employees does RegeneRx Biopharmaceuticals have?

RegeneRx Biopharmaceuticals has 3 employees as of Feb 6, 2024.

RegeneRx Biopharmaceuticals - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Pharmaceuticals
  • Therapeutics
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 20 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 541110Offices of Lawyers
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 541100Legal Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 8100Legal Services
  • 8110Legal Services
  • 8111Legal Services
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 6910Legal activities